IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1

CUSIP: 46333XAH1

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Debt / NOTE 1.500% 6/1
Market price (% of par)
94.72%
Total 13F principal
$183,507,000
Principal change
+$12,683,923
Total reported market value
$177,678,590
Number of holders
12
Value change
+$17,140,925
Number of buys
8
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 46333XAH1?
CUSIP 46333XAH1 identifies 46333XAH1 - IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 as of Q4 2025

As of 31 Dec 2025, IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 was held by 12 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $183,507,000 in principal (par value) of the bond. The largest 10 bondholders included BRAIDWELL LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Context Capital Management, LLC, DeepCurrents Investment Group LLC, D. E. Shaw & Co., Inc., ADVENT CAPITAL MANAGEMENT /DE/, ZAZOVE ASSOCIATES LLC, JPMORGAN CHASE & CO, Advisory Services Network, LLC, and Jefferies Financial Group Inc.. This page lists 12 institutional bondholders reporting positions for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.